Advertisement
U.S. markets open in 2 hours 25 minutes

Bavarian Nordic A/S (BAVA.CO)

Copenhagen - Copenhagen Real Time Price. Currency in DKK
157.25-0.15 (-0.10%)
As of 12:02PM CET. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close157.40
Open156.45
Bid157.05 x 0
Ask157.25 x 0
Day's Range155.50 - 158.35
52 Week Range125.55 - 222.00
Volume116,356
Avg. Volume557,954
Market Cap12.257B
Beta (5Y Monthly)1.34
PE Ratio (TTM)8.19
EPS (TTM)19.20
Earnings DateMay 08, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est277.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BAVA.CO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland

      COPENHAGEN, Denmark, March 13, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved JYNNEOS® (MVA-BN) for active immunization against disease caused by smallpox, mpox and vaccinia viruses in adults 18 years of age and older. The approval represents the first national marketing authorization issued to Bavarian Nordic since 2019 and was facilitated by the Swiss authorities in response to the 2022 global mpox outbreak. Durin

    • GlobeNewswire

      Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

      COPENHAGEN, Denmark, March 12, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such, which are hereby reported in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523. The transactions concern the vesting of restricted stock units (RSUs) including matc

    • GlobeNewswire

      Bavarian Nordic Publishes Annual Report 2023

      COPENHAGEN, Denmark, March 6, 2024 – Bavarian Nordic A/S (OMX: BAVA) today published its Annual Report for 2023. The consolidated, audited results were in line with the preliminary results, announced on February 21, 2024, and exceeded prior guidance. The full report is attached as a PDF file and can be found on the Company's website, www.bavarian-nordic.com. Paul Chaplin, President & Chief Executive Officer of Bavarian Nordic said: “Delivering our best-ever financial results in 2023, we are now